Adagio Medical Reports Second Quarter 2025 Results
LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac a...
How might the market react to the enrollment milestone and any potential data readout from the pivotal study?
What is the expected pricing and reimbursement landscape for the vCLAS™ Cryoablation System upon launch?
Are there any partnership or licensing agreements in place that could be impacted by the study results?
21 days ago